This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Valcuria Ab. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Catharina Salomonsson: Innovator in Cancer Treatment
Introduction
Catharina Salomonsson is a notable inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. Her innovative work focuses on developing effective methods for pretreating cancer using specific pharmaceutical compositions.
Latest Patents
Catharina holds 1 patent related to her invention titled "Composition and method for pretreating cancer." This patent describes a pharmaceutical composition that includes an HDAC inhibitor, which is provided in both immediate release and extended release forms. The composition is designed to enhance the effectiveness of cancer treatment by ensuring that 70-90 weight % of the HDAC inhibitor is available in the immediate release form, while the remainder is in the extended release form. Additionally, the invention encompasses a kit that includes doses of the HDAC inhibitor for use in cancer pretreatment.
Career Highlights
Catharina is associated with Valcuria AB, where she continues to advance her research and development efforts. Her work is pivotal in the ongoing fight against cancer, showcasing her commitment to improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Catharina collaborates with notable colleagues, including Johan Drott and Kristina Drott. Their combined expertise contributes to the success of their projects and enhances the impact of their innovations in the medical field.
Conclusion
Catharina Salomonsson's contributions to cancer treatment through her innovative patent demonstrate her dedication to advancing medical science. Her work at Valcuria AB and collaborations with esteemed colleagues further solidify her role as a key figure in the pharmaceutical industry.